Humira

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2017
010203020032017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
PURPOSE To evaluate the ocular toxicity of escalating doses of intravitreous adalimumab (Humira®) in the rabbit eye. METHODS… (More)
Is this relevant?
2009
2009
PROBLEM The purpose of this study was to investigate whether treatment with TNF-alpha inhibitors and/or intravenous… (More)
  • table I
Is this relevant?
2009
2009
The purpose of this study is to evaluate the retinal toxicity of two doses of adalimumab (Humira), a recombinant human IgG1… (More)
  • figure 1
  • figure 2
Is this relevant?
2008
2008
To evaluate the ocular toxicity of escalating doses of intravitreous adalimumab (Humira) in the rabbit eye. Twelve New Zealand… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE Chronic anterior uveitis in children often takes a serious course. Despite various immunosuppressive drugs some children… (More)
Is this relevant?
2005
2005
OBJECTIVES To determine whether the tumour necrosis factor-alpha (TNF-alpha) antagonist adalimumab (Humira) can be efficacious… (More)
Is this relevant?
2005
2005
Adalimumab is a fully humanized IgG1 monoclonal antibody to tumor necrosis factor-a. We describe 2 patients (17 and 13 years of… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE This study, known as STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis), evaluated the safety and efficacy of… (More)
Is this relevant?